Chlorine in PDB 5ohj: Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
Enzymatic activity of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
All present enzymatic activity of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.:
3.1.4.53;
Protein crystallography data
The structure of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor., PDB code: 5ohj
was solved by
A.Rizzi,
L.Carzaniga,
E.Armani,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
29.61 /
1.60
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
55.270,
55.730,
225.560,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
18.4 /
21.2
|
Other elements in 5ohj:
The structure of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor. also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
(pdb code 5ohj). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor., PDB code: 5ohj:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 5ohj
Go back to
Chlorine Binding Sites List in 5ohj
Chlorine binding site 1 out
of 4 in the Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl801
b:16.5
occ:1.00
|
CL
|
A:9VE801
|
0.0
|
16.5
|
1.0
|
C26
|
A:9VE801
|
1.7
|
15.3
|
1.0
|
C27
|
A:9VE801
|
2.7
|
17.8
|
1.0
|
C25
|
A:9VE801
|
2.7
|
13.6
|
1.0
|
C24
|
A:9VE801
|
3.1
|
14.4
|
1.0
|
O2
|
A:9VE801
|
3.4
|
16.4
|
1.0
|
O
|
A:HOH784
|
3.5
|
23.1
|
1.0
|
O3
|
A:9VE801
|
3.7
|
18.1
|
1.0
|
CE1
|
A:PHE586
|
3.8
|
15.0
|
1.0
|
C9
|
A:9VE801
|
3.8
|
15.1
|
1.0
|
CZ
|
A:PHE586
|
3.9
|
15.2
|
1.0
|
N2
|
A:9VE801
|
4.0
|
17.6
|
1.0
|
C13
|
A:9VE801
|
4.0
|
16.1
|
1.0
|
C29
|
A:9VE801
|
4.0
|
15.4
|
1.0
|
O4
|
A:9VE801
|
4.1
|
16.2
|
1.0
|
CE1
|
A:HIS406
|
4.2
|
12.1
|
1.0
|
C15
|
A:9VE801
|
4.2
|
16.8
|
1.0
|
O
|
A:HOH750
|
4.3
|
15.9
|
1.0
|
C10
|
A:9VE801
|
4.3
|
14.2
|
1.0
|
CD1
|
A:ILE582
|
4.4
|
14.3
|
1.0
|
C11
|
A:9VE801
|
4.5
|
15.3
|
1.0
|
C28
|
A:9VE801
|
4.5
|
17.5
|
1.0
|
C14
|
A:9VE801
|
4.6
|
17.6
|
1.0
|
O
|
A:HOH751
|
4.6
|
25.4
|
1.0
|
NE2
|
A:HIS406
|
4.6
|
12.2
|
1.0
|
O
|
A:HOH748
|
4.7
|
14.2
|
1.0
|
C8
|
A:9VE801
|
4.8
|
13.8
|
1.0
|
N1
|
A:9VE801
|
4.9
|
17.2
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 5ohj
Go back to
Chlorine Binding Sites List in 5ohj
Chlorine binding site 2 out
of 4 in the Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl801
b:17.7
occ:1.00
|
CL1
|
A:9VE801
|
0.0
|
17.7
|
1.0
|
C29
|
A:9VE801
|
1.7
|
15.4
|
1.0
|
C28
|
A:9VE801
|
2.7
|
17.5
|
1.0
|
C25
|
A:9VE801
|
2.7
|
13.6
|
1.0
|
C24
|
A:9VE801
|
3.1
|
14.4
|
1.0
|
O
|
A:HOH737
|
3.3
|
11.9
|
1.0
|
C9
|
A:9VE801
|
3.5
|
15.1
|
1.0
|
OD2
|
A:ASP564
|
3.5
|
13.0
|
1.0
|
O
|
A:HOH714
|
3.6
|
16.3
|
1.0
|
CD2
|
A:LEU565
|
3.6
|
14.3
|
1.0
|
O
|
A:HOH760
|
3.8
|
13.9
|
1.0
|
CG
|
A:ASP564
|
3.8
|
11.8
|
1.0
|
N2
|
A:9VE801
|
3.9
|
17.6
|
1.0
|
C26
|
A:9VE801
|
4.0
|
15.3
|
1.0
|
OD1
|
A:ASP564
|
4.1
|
11.0
|
1.0
|
O6
|
A:9VE801
|
4.2
|
15.1
|
1.0
|
CG
|
A:MET519
|
4.2
|
16.3
|
1.0
|
O
|
A:ASP564
|
4.2
|
12.7
|
1.0
|
O
|
A:HOH745
|
4.2
|
15.6
|
1.0
|
CG
|
A:LEU565
|
4.3
|
13.2
|
1.0
|
O2
|
A:9VE801
|
4.4
|
16.4
|
1.0
|
CB
|
A:ASP564
|
4.5
|
11.6
|
1.0
|
C27
|
A:9VE801
|
4.5
|
17.8
|
1.0
|
C
|
A:ASP564
|
4.6
|
11.8
|
1.0
|
C8
|
A:9VE801
|
4.6
|
13.8
|
1.0
|
C10
|
A:9VE801
|
4.6
|
14.2
|
1.0
|
C30
|
A:9VE801
|
4.8
|
14.7
|
1.0
|
SD
|
A:MET519
|
4.9
|
19.0
|
1.0
|
O
|
A:THR517
|
4.9
|
13.4
|
1.0
|
O7
|
A:9VE801
|
5.0
|
35.5
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 5ohj
Go back to
Chlorine Binding Sites List in 5ohj
Chlorine binding site 3 out
of 4 in the Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl801
b:20.7
occ:1.00
|
CL
|
B:9VE801
|
0.0
|
20.7
|
1.0
|
C26
|
B:9VE801
|
1.7
|
18.8
|
1.0
|
C27
|
B:9VE801
|
2.7
|
19.4
|
1.0
|
C25
|
B:9VE801
|
2.7
|
19.1
|
1.0
|
C24
|
B:9VE801
|
3.1
|
18.6
|
1.0
|
O2
|
B:9VE801
|
3.4
|
18.3
|
1.0
|
O
|
B:HOH750
|
3.6
|
23.9
|
1.0
|
O3
|
B:9VE801
|
3.7
|
26.0
|
1.0
|
CE1
|
B:PHE586
|
3.8
|
16.4
|
1.0
|
C9
|
B:9VE801
|
3.9
|
18.3
|
1.0
|
CZ
|
B:PHE586
|
4.0
|
16.5
|
1.0
|
N2
|
B:9VE801
|
4.0
|
20.4
|
1.0
|
C29
|
B:9VE801
|
4.0
|
18.1
|
1.0
|
C13
|
B:9VE801
|
4.1
|
23.7
|
1.0
|
CE1
|
B:HIS406
|
4.1
|
15.5
|
1.0
|
O4
|
B:9VE801
|
4.2
|
21.1
|
1.0
|
C15
|
B:9VE801
|
4.3
|
25.3
|
1.0
|
C10
|
B:9VE801
|
4.3
|
21.1
|
1.0
|
O
|
B:HOH749
|
4.3
|
17.7
|
1.0
|
CD1
|
B:ILE582
|
4.4
|
14.4
|
1.0
|
O
|
B:HOH723
|
4.5
|
34.4
|
1.0
|
C28
|
B:9VE801
|
4.5
|
20.2
|
1.0
|
C11
|
B:9VE801
|
4.5
|
21.9
|
1.0
|
NE2
|
B:HIS406
|
4.7
|
14.3
|
1.0
|
C14
|
B:9VE801
|
4.7
|
25.8
|
1.0
|
O
|
B:HOH748
|
4.7
|
18.0
|
1.0
|
C8
|
B:9VE801
|
4.9
|
17.0
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 5ohj
Go back to
Chlorine Binding Sites List in 5ohj
Chlorine binding site 4 out
of 4 in the Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl801
b:20.1
occ:1.00
|
CL1
|
B:9VE801
|
0.0
|
20.1
|
1.0
|
C29
|
B:9VE801
|
1.7
|
18.1
|
1.0
|
C28
|
B:9VE801
|
2.6
|
20.2
|
1.0
|
C25
|
B:9VE801
|
2.7
|
19.1
|
1.0
|
C24
|
B:9VE801
|
3.1
|
18.6
|
1.0
|
O
|
B:HOH725
|
3.3
|
14.4
|
1.0
|
OD2
|
B:ASP564
|
3.4
|
14.0
|
1.0
|
C9
|
B:9VE801
|
3.6
|
18.3
|
1.0
|
O
|
B:HOH702
|
3.6
|
20.9
|
1.0
|
CD2
|
B:LEU565
|
3.7
|
15.5
|
1.0
|
CG
|
B:ASP564
|
3.7
|
13.4
|
1.0
|
O
|
B:HOH706
|
3.7
|
16.2
|
1.0
|
N2
|
B:9VE801
|
3.9
|
20.4
|
1.0
|
C26
|
B:9VE801
|
4.0
|
18.8
|
1.0
|
OD1
|
B:ASP564
|
4.1
|
13.6
|
1.0
|
O
|
B:HOH752
|
4.1
|
17.8
|
1.0
|
O6
|
B:9VE801
|
4.2
|
20.9
|
1.0
|
O
|
B:ASP564
|
4.2
|
14.9
|
1.0
|
CG
|
B:MET519
|
4.3
|
17.7
|
1.0
|
CG
|
B:LEU565
|
4.3
|
13.4
|
1.0
|
O2
|
B:9VE801
|
4.4
|
18.3
|
1.0
|
CB
|
B:ASP564
|
4.4
|
13.4
|
1.0
|
C27
|
B:9VE801
|
4.4
|
19.4
|
1.0
|
C
|
B:ASP564
|
4.5
|
13.4
|
1.0
|
C10
|
B:9VE801
|
4.7
|
21.1
|
1.0
|
C8
|
B:9VE801
|
4.7
|
17.0
|
1.0
|
SD
|
B:MET519
|
4.8
|
21.8
|
1.0
|
C30
|
B:9VE801
|
4.9
|
17.5
|
1.0
|
O
|
B:THR517
|
4.9
|
15.8
|
1.0
|
O
|
B:HOH748
|
4.9
|
18.0
|
1.0
|
O7
|
B:9VE801
|
5.0
|
25.1
|
1.0
|
|
Reference:
L.Carzaniga,
G.Amari,
A.Rizzi,
C.Capaldi,
R.De Fanti,
E.Ghidini,
G.Villetti,
C.Carnini,
N.Moretto,
F.Facchinetti,
P.Caruso,
G.Marchini,
L.Battipaglia,
R.Patacchini,
V.Cenacchi,
R.Volta,
F.Amadei,
A.Pappani,
S.Capacchi,
V.Bagnacani,
M.Delcanale,
P.Puccini,
S.Catinella,
M.Civelli,
E.Armani.
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives As Inhaled PDE4 Inhibitors For Respiratory Diseases. J. Med. Chem. V. 60 10026 2017.
ISSN: ISSN 1520-4804
PubMed: 29200281
DOI: 10.1021/ACS.JMEDCHEM.7B01044
Page generated: Fri Jul 26 14:29:40 2024
|